Veranex Acquires HORUS Scientific
May 1, 2024
Veranex has acquired HORUS Scientific, a pathology and histology provider, to deepen its preclinical pathology and histology capabilities and expand its North American service footprint. The acquisition adds specialized GLP-capable histopathology services to Veranex’s integrated medtech service platform and complements its existing Paris pathology capabilities.
- Buyers
- Veranex
- Targets
- HORUS Scientific
- Platforms
- Veranex
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Horus Pharma Acquires Significant Stake in Inocare Pharm
November 5, 2024
Medical Devices
Horus Pharma has purchased a significant participation in Inocare Pharm, a Bucharest-based company that commercializes ophthalmic medical devices, diagnostic instruments and dietary supplements. The investment — Horus Pharma's first outside France — is intended to expand Horus's presence into Romania, the Balkans and CIS markets while strengthening Inocare Pharm's product portfolio and market position.
-
Veranex Acquires T3 Labs
December 13, 2023
Medical Devices
Veranex has acquired T3 Labs, a preclinical laboratory based in Atlanta, Georgia. The acquisition expands Veranex's preclinical footprint in North America and deepens its medical‑device testing and therapeutic expertise to provide more integrated services to medtech clients.
-
Veranex Acquires Fusion Biotec
December 13, 2022
Medical Devices
Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.
-
Veranex Acquires IMMR (Paris-based Preclinical Services)
October 12, 2021
Medical Devices
Veranex, a global concept-to-commercialization service provider for the MedTech industry, has acquired IMMR, a Paris-based preclinical science organization providing GLP-compliant preclinical research, pathology evaluation and surgical training. The acquisition expands Veranex's preclinical capabilities with IMMR's FDA-inspected and AAALAC-accredited facilities and expert surgical teams; financial terms were not disclosed.
-
Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates
June 16, 2021
Healthcare Services
Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.
-
Inotiv Acquires HistoTox Labs
April 13, 2021
Healthcare Services
Inotiv, Inc. has entered into an agreement to purchase substantially all assets of HistoTox Labs, a histopathology contract research organization, for $22.0 million in cash. The acquisition (subject to financing and customary closing conditions) expands Inotiv's pathology and histology capabilities, adds a Boulder, Colorado facility with digital pathology and immunohistochemistry capabilities, and is expected to retain all HistoTox employees.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.